Lecithin is a mix of phospholipids (mostly phosphatidylcholine, with smaller amounts of phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, and phosphatidic acid) pulled from soybeans or sunflower seeds. Most people take it for one of three reasons: as a cheap source of choline, to support liver health (especially if they have fatty liver or drink regularly), or, in breastfeeding women, to help with recurrent clogged milk ducts.
It's one of the more boring supplements on the shelf, and that's the point. It's not a nootropic in the felt-effect sense. It's a structural nutrient. Phosphatidylcholine is the building block of every cell membrane in your body and the precursor your brain uses to make acetylcholine. Most adults under-consume choline, women especially during pregnancy and breastfeeding, and lecithin is one of the cleanest, cheapest ways to backfill that gap without raising the cardiovascular markers that other forms of choline can.
Deep-dive
Soy vs sunflower, the actual difference. Both contain the same core phospholipids and produce the same physiological effects. The differences are practical, not biological. Sunflower lecithin is typically higher in phosphatidylcholine (usually 20-25% vs 15-20% in soy), is non-GMO by default, has a milder taste, and is extracted mechanically by cold-press rather than with hexane. Soy lecithin is cheaper, more abundant, and has a slightly different phospholipid balance with more phosphatidylinositol. The isoflavone concern with soy lecithin is largely a myth: analytical work on isoflavone exposure consistently finds soy lecithin contains negligible amounts of genistein or daidzein because the isoflavones migrate with the protein fraction during processing, not the lipid fraction. If you're avoiding soy for allergy or non-GMO reasons, pick sunflower. If you're avoiding it because of phytoestrogens, the data doesn't support that worry at supplement doses.
The choline mechanism. Phosphatidylcholine is roughly 13% choline by weight, which means a 1200 mg lecithin capsule (typically 20-25% PC by weight) delivers somewhere between 30-80 mg of choline. That's not a heavy dose, but it stacks meaningfully on top of dietary intake. Adequate intake is 425 mg/day for women, 550 mg/day for men, 450 mg in pregnancy, and 550 mg during lactation, and most people fall well short, especially women on plant-heavy diets. German survey data found median intake in pregnant women was 260 mg/day, with only 7% hitting adequate intake. Once absorbed, phosphatidylcholine is incorporated directly into cell membranes (especially in the liver and brain) or hydrolysed to release free choline, which then feeds into three pathways: acetylcholine synthesis (memory, attention, neuromuscular function), methyl-group metabolism via betaine (DNA methylation, homocysteine clearance), and VLDL packaging in the liver (how the liver exports fat).
The TMAO question, and why phosphatidylcholine is the right form. Choline can be metabolised by gut bacteria into trimethylamine, which the liver converts into TMAO. Higher TMAO levels are linked with elevated cardiovascular risk in multiple meta-analyses, and this is the main concern people raise about supplementing choline. The important nuance is that not all choline forms produce TMAO equally. In a randomised crossover trial in 37 healthy men, 600 mg of choline as choline bitartrate raised plasma TMAO three-fold over baseline, while the same dose as phosphatidylcholine raised it no more than placebo. A separate RCT in healthy adults found that choline bitartrate raised both TMAO and platelet reactivity, while eggs and phosphatidylcholine supplements did not. The mechanism: free choline (bitartrate) is largely available to gut bacteria, while phosphatidylcholine is absorbed mostly intact via the lymphatic system, bypassing the bacterial conversion. If you care about choline and care about cardiovascular markers, lecithin is the form that splits the difference.
Liver health. This is the strongest evidence base outside of breastfeeding. Polyenylphosphatidylcholine (a purified soy lecithin extract, sold as 'essential phospholipids') has been studied in fatty liver disease for decades. A 2020 systematic review and network meta-analysis of trials in NAFLD patients with type 2 diabetes or obesity found EPL reduced steatosis (visible fat on ultrasound or CT) and lowered ALT compared to standard care alone. The MANPOWER real-world study in over 2,800 NAFLD patients reported reductions in ALT, AST, and triglycerides over six months with 1.8 g/day of phosphatidylcholine. The mechanism is straightforward: phosphatidylcholine is the limiting nutrient for assembling VLDL particles, the boats the liver uses to ship triglycerides out. When PC is low, fat accumulates inside hepatocytes. When it's restored, the export resumes. This is also why methionine-and-choline-deficient diets are the classic rodent model for fatty liver.
Cognition. The story is mixed and depends on whether you're looking at supplementation or dietary intake. The Kuopio Ischaemic Heart Disease Risk Factor Study, following 2,497 Finnish men over 22 years, found those in the highest quartile of dietary phosphatidylcholine intake (>222 mg/day) had a 28% lower risk of incident dementia, independent of APOE-ε4 status. That's a clean signal that more PC across decades tracks with less dementia. However, the 2003 Cochrane meta-analysis of lecithin trials in Alzheimer's, Parkinson's, and subjective memory impairment found no convincing cognitive benefit, with the caveat that most trials were short and may not have caught the slow structural effect that the epidemiology suggests. The honest read: lecithin is not a felt cognitive enhancer in the way Alpha-GPC or CDP Choline can be acutely. It's a long-game choline source, more like a structural input than a nootropic. If you want acute cognitive lift, those forms cross the blood-brain barrier faster and dose choline more efficiently per capsule. If you want a cheap baseline that also supports liver and cardiovascular markers, lecithin is fine.
Ulcerative colitis. Phosphatidylcholine is a major component of the protective mucus layer lining the colon, and patients with ulcerative colitis have been shown to have roughly 70% less PC in their colonic mucus than healthy controls. A meta-analysis of three trials with delayed-release phosphatidylcholine (LT-02) found significant improvement in remission rates, endoscopic findings, and quality of life vs placebo, with no excess side effects. This requires a specific delayed-release formulation (so the PC reaches the colon intact) and is not what you get from a standard lecithin capsule, but it's a meaningful mechanistic clue for anyone with UC.
Breastfeeding and clogged ducts. This is the most-recommended use in clinical practice despite weak formal evidence. The LactMed database notes that no high-quality clinical trials exist for high-dose lecithin in nursing mothers, but the case-report and consensus base is large enough that the Academy of Breastfeeding Medicine and major institutions like UI Health Care routinely recommend it. The proposed mechanism, that lecithin reduces milk 'stickiness' and prevents clogs, may be outdated (newer thinking attributes clogs to inflammation rather than congealed milk), but the dose-response observed in practice is consistent enough that it remains first-line. Standard protocol is 3,600-4,800 mg/day for recurrent clogged ducts.
Women. Choline demand is meaningfully higher across the female lifespan, especially during pregnancy and lactation. Oestrogen upregulates endogenous PC synthesis via the PEMT pathway, which partially compensates for low dietary intake, but a common SNP in the PEMT gene means around 40-50% of women have impaired endogenous synthesis and are functionally choline-dependent even premenopausally. After menopause, oestrogen drops, PEMT activity falls, and dietary need rises further. Practically: women on plant-heavy or egg-light diets are the group most likely to benefit from lecithin, and pregnant women are the group with the strongest case for active supplementation (the 450 mg/day target during pregnancy is met by fewer than 10% of women in most surveys). Pregnant women using prenatal supplements should check the label, choline is often missing or underdosed. Lecithin is one way to fill that gap, although direct phosphatidylcholine or CDP Choline at modest doses are also reasonable.
Dosage:
- General choline support: 1,200-2,400 mg lecithin/day, taken with food. Delivers approximately 50-150 mg of choline depending on the PC concentration of the product
- Liver support (fatty liver, regular alcohol use, post-binge): 1,800 mg phosphatidylcholine/day, which usually means 5-9 grams of standard lecithin or 1.8 g of a concentrated PC product. This is the dose used in the NAFLD trials
- Recurrent clogged milk ducts (breastfeeding): 3,600-4,800 mg/day in divided doses (one 1,200 mg capsule, 3-4 times daily). Reduce by one capsule every 2 weeks once clear, maintain at the lowest dose that prevents recurrence
- Pregnancy (choline gap): if your prenatal doesn't include choline, 1,200-2,400 mg lecithin/day is a low-friction way to add roughly 50-150 mg of choline. For larger gaps, choline-specific supplements are more efficient. Do not exceed 3,500 mg/day total choline from all sources during pregnancy
- Form: powder or liquid lecithin is the cheapest per gram of PC and mixes into smoothies or oatmeal. Capsules are easier but more expensive. Concentrated 'essential phospholipid' or 'PPC' products deliver higher PC per dose if you want the liver-protective dose without taking a handful of capsules
- Soy vs sunflower: physiologically equivalent. Pick sunflower if you have soy allergy, prefer non-GMO, or want a slightly higher PC concentration per gram. Soy is fine and cheaper if neither matters to you
- Timing: take with a meal containing fat for best absorption. Splitting the dose across the day matters more than time of day. No stimulant effect, so it won't disrupt sleep
- Stacks: pairs naturally with Omega-3 (both feed membrane phospholipid synthesis), Vitamin E (protects the polyunsaturated fatty acids in lecithin from oxidation), and Milk Thistle or NAC if you're stacking for liver support
Here's what you can expect:
If you're using it for general choline or membrane support, you won't feel anything. This is normal, and not a sign it's not working. The benefits show up on bloodwork (ALT, lipid panel) and in long-arc outcomes (cognitive aging, liver health) rather than in your subjective day.
If you're using it for fatty liver, expect to see ALT and triglyceride changes by 2-3 months, with most of the studied benefit landing at 6 months. Lecithin doesn't replace lifestyle changes (weight loss, alcohol reduction, glycemic control), it works alongside them.
If you're using it for clogged ducts, the timeline is usually 24-48 hours for an acute episode and 1-2 weeks of consistent dosing to prevent recurrence. If clogs persist at full dose for more than a week, the issue is usually mechanical (latch, pump fit, missed feeds) and lecithin won't fix it.
If you're using it as a nootropic, you'll likely be disappointed. Lecithin is a slow background input, not an acute lever. For felt cognitive effects, Alpha-GPC or CDP Choline are the better tools.
Side effects & risks:
- GI effects are the most common. Nausea, bloating, loose stools, or a 'fishy' or 'ammonia' body odour at high doses (above 5-6 g/day). The body odour comes from increased TMA production by gut bacteria, more on this below. Splitting the dose with food usually resolves both
- TMAO at very high doses. While phosphatidylcholine raises TMAO far less than free choline, intakes above 5-6 g of PC per day can start to push TMAO up modestly, especially in people with TMAO-producer gut microbiomes. For the typical 1-2 g dose, this is not a meaningful concern. If you're running the higher liver-support doses chronically and have known cardiovascular risk, get a baseline TMAO
- Soy allergy. Soy lecithin contains trace residual soy proteins and can trigger reactions in soy-allergic individuals, although most allergy bodies consider it low-risk. If you have a confirmed soy allergy, sunflower is the safer pick
- Lipid oxidation. Lecithin is rich in polyunsaturated fatty acids, which oxidise on exposure to heat, light, and air. A rancid lecithin tastes and smells unpleasant and may be pro-inflammatory rather than helpful. Store in the fridge once opened (especially liquid forms) and don't buy in bulk if you won't use it within a few months
- Bipolar disorder. A handful of older case reports suggest very high-dose lecithin (10g+ daily) may worsen depressive symptoms in some bipolar patients, possibly via the acetylcholine pathway. Evidence is thin but worth flagging
- Pregnancy and breastfeeding. Considered safe at typical doses and routinely used during lactation. Don't exceed 3,500 mg/day of total choline from all sources, the upper intake level set during pregnancy. Lecithin contributes only a fraction of this, but stacking with a choline-rich diet plus a high-choline prenatal can add up
- Drug interactions are minimal. Lecithin can mildly enhance absorption of fat-soluble compounds taken at the same time, which is usually neutral or helpful. No meaningful interactions with common medications. If you're on warfarin, very high doses (rare) could theoretically affect lipid handling but this isn't a documented clinical issue
Blood markers
ALT and AST, baseline and at 3-6 months if you're using lecithin for liver support. The NAFLD evidence is built around these markers and they're the practical way to track whether it's working for you.
Full lipid panel (LDL, HDL, triglycerides), baseline and at 6 months. Phosphatidylcholine modestly improves the lipid profile in most trials, particularly triglycerides, and is one of the better tracking markers for chronic use.
TMAO, only if you're running 5+ g of PC daily for liver or other indications and have cardiovascular risk factors. At typical doses (1-2 g) this is not necessary.
Homocysteine, useful as a downstream marker of methyl-group metabolism since choline (via betaine) supports homocysteine clearance. If yours is elevated and B12/folate are adequate, choline insufficiency is a possible contributor.
For most people taking lecithin as a general choline source at 1-2 g/day, no specific bloodwork is needed. Baseline ALT and a lipid panel are useful if you're running higher liver-support doses chronically, in pregnancy, or in anyone with NAFLD risk factors (overweight, diabetic, regular drinker).
Sold as a dietary supplement and food additive in most countries without prescription.
